Market Place
Sourcing Support
Gelesis’ Oral Treatment for Weight Management Showed Real-World Effectiveness
26 Jun 2023 //
BUSINESSWIRE
Gelesis Reports Fourth Quarter and Full Year 2022 Results
28 Mar 2023 //
BUSINESSWIRE
Gelesis to Participate in the 25th Annual ICR Conference
05 Jan 2023 //
BUSINESSWIRE
Gelesis Receives Notice of NYSE Market Capitalization Rule Non-Compliance
18 Nov 2022 //
BUSINESSWIRE
Gelesis Reports Third Quarter 2022 Results
14 Nov 2022 //
BUSINESSWIRE
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance
04 Nov 2022 //
BUSINESSWIRE
Dr. Frank Greenway to Present Data from LIGHT-UP Study Gelesis’ Oral Hydrogel
01 Nov 2022 //
BUSINESSWIRE
Gelesis Reports Second Quarter 2022 Results
15 Aug 2022 //
BUSINESSWIRE
Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022
04 Aug 2022 //
BUSINESSWIRE
Gelesis Announces Additional $15M Pre-Order for Plenity
21 Jun 2022 //
BUSINESSWIRE
Gut Bacteria Contributes Beneficial Metabolic Effects with Gelesis’ Hydrogel
04 Jun 2022 //
BUSINESSWIRE
Gelesis to Participate in Upcoming Investor Conferences
18 May 2022 //
BUSINESSWIRE
Gelesis Reports First Quarter 2022 Results
12 May 2022 //
BUSINESSWIRE
Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
09 May 2022 //
BUSINESSWIRE
Gelesis Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook
24 Mar 2022 //
BUSINESSWIRE
Gelesis Releases Preliminary National Launch Results for Plenity
16 Mar 2022 //
BUSINESSWIRE
Gelesis Will Debut as Publicly Traded Company
13 Jan 2022 //
BUSINESSWIRE
PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
18 Nov 2021 //
BUSINESSWIRE
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports
01 Nov 2021 //
BUSINESSWIRE
Obesity devicemaker Gelesis maps out $1.3B SPAC deal
20 Jul 2021 //
FIERCEBIOTECH
PureTech-backed Gelesis wins latest SPAC deal
19 Jul 2021 //
ENDPTS
Post-Hoc Analysis Showed Plenity®-Induced Weight Loss Resulted in NALFD
27 May 2021 //
WVNEWS
Plenity Efficacy and Safety Data to be Presented at the European & Congress
04 Sep 2020 //
BUSINESSWIRE
Gelesis Secures Over $84 Million in New Capital to Support Commercialization of PLENITY™
09 Dec 2019 //
BUSINESSWIRE
New Plenity™ Pivotal Safety & Efficacy Data to be Presented at ObesityWeek 2019
29 Oct 2019 //
BUSINESSWIRE
Gelesis Raises $30 Million to Prepare for Potential Launch of Lead Product
01 Mar 2018 //
PRESS RELEASE
PureTech’s Gelesis brings in $30M to back its FDA pitch
01 Mar 2018 //
MYLAN INC.
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.